OphSourceHomeJournal CollectionOphSource ShopEvents
Journal Home
Search for

Volume 109, Issue 11, Pages 2112-2117 (November 2002)


View previous. 45 of 56 View next.

Transconjunctival lower eyelid involutional entropion repair: Long-term follow-up and efficacy

Presented in part at the annual meeting of the American Academy of Ophthalmology, New Orleans, Louisiana, November 2001.

Shawn J Khan, MD1, Dale R Meyer, MD, FASC1Corresponding Author Information

Received 23 October 2001; accepted 8 April 2002.

Abstract 

Objective

To evaluate the safety and long-term efficacy of a modified transconjunctival involutional lower eyelid entropion repair.

Design

Retrospective, noncomparative case series and survey.

Participants

Eighty-nine consecutive patients with involutional entropion (114 eyelids).

Methods

Modified transconjunctival involutional lower eyelid entropion repair technique was performed on 114 eyelids of 89 consecutive patients over a 7-year period. All cases had a minimum of 3 months of initial office follow-up, with extended follow-up obtained via standardized telephone interviews.

Main outcome measures

Surgical success and entropion recurrence.

Results

Surgery was completed successfully with no complications in all 114 cases. All cases demonstrated correction of entropion at the 3-month office follow-up. Long-term follow-up (mean, 38.3 months; range, 4–85 months) was obtained in 75% of cases. Recurrence was noted in only one patient (two eyelids [2%]).

Conclusions

Modified transconjunctival lower eyelid entropion repair is a time-efficient, safe, and efficacious technique. In contrast to a recent report using another transconjunctival technique, we found a relatively low rate of recurrence on extended follow-up.

1 The Lions Eye Institute, Department of Ophthalmology, Albany Medical College, Albany, New York, USA

Corresponding Author InformationCorrespondence to Dale R. Meyer, MD, Lions Eye Institute, 35 Hackett Boulevard, Albany, NY 12008, USA.

 The authors have no financial or proprietary interest in any aspect of this study.

PII: S0161-6420(02)01259-9


View previous. 45 of 56 View next.